Americana Partners LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 30,938 shares of the healthcare conglomerate’s stock, valued at approximately $11,357,000.
A number of other large investors have also bought and sold shares of the business. Left Brain Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 480.4% during the third quarter. Left Brain Wealth Management LLC now owns 5,816 shares of the healthcare conglomerate’s stock worth $2,135,000 after buying an additional 4,814 shares in the last quarter. Modera Wealth Management LLC lifted its stake in UnitedHealth Group by 1.9% in the 3rd quarter. Modera Wealth Management LLC now owns 9,884 shares of the healthcare conglomerate’s stock valued at $3,628,000 after acquiring an additional 185 shares in the last quarter. State of Wyoming lifted its stake in UnitedHealth Group by 279.3% in the 3rd quarter. State of Wyoming now owns 5,742 shares of the healthcare conglomerate’s stock valued at $2,108,000 after acquiring an additional 4,228 shares in the last quarter. CFC Planning Co LLC boosted its position in UnitedHealth Group by 9.0% during the 3rd quarter. CFC Planning Co LLC now owns 17,787 shares of the healthcare conglomerate’s stock worth $6,530,000 after acquiring an additional 1,471 shares during the last quarter. Finally, Petros Family Wealth LLC grew its stake in shares of UnitedHealth Group by 4.4% during the 3rd quarter. Petros Family Wealth LLC now owns 9,323 shares of the healthcare conglomerate’s stock worth $3,422,000 after acquiring an additional 392 shares in the last quarter. 87.86% of the stock is owned by institutional investors.
Key UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: Improving margins and higher price target: Morgan Stanley said UnitedHealth’s margins are recovering, with Medicare operations returning to a more normal range, and raised its price target. However, commercial insurance, Medicaid and increased AI-related spending remain important execution tests. UnitedHealth is bouncing back, but a major risk remains
- Positive Sentiment: Recent earnings beat and raised guidance: UnitedHealth’s latest quarterly results exceeded expectations for both earnings and revenue, and the company raised its outlook. The earnings recovery supports the case that operating performance is stabilizing after earlier pressure. Why Did UnitedHealth Raise Guidance After Its Quarterly Beat?
- Positive Sentiment: Dividend appeal: UnitedHealth is highlighted as a major healthcare dividend payer, potentially supporting demand from income-focused investors. The article also cautions that dividend safety should be assessed alongside payout sustainability and business risks. $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends
- Neutral Sentiment: Analyst estimates are mixed: Zacks Research maintained a “Hold” rating and projects roughly $20.54 in FY2026 EPS, close to the broader consensus near $20.62. It raised several longer-term quarterly estimates but lowered others, including Q1 2027, Q1 2028 and Q2 2028.
- Negative Sentiment: Near-term earnings pressure: Zacks Research issued a negative estimate for fourth-quarter earnings, adding to concerns that high medical utilization and costs could limit profitability despite the Medicare recovery. Zacks Research Has Negative Estimate for UNH Q4 Earnings
Wall Street Analysts Forecast Growth
UNH has been the topic of a number of research reports. New Street Research set a $402.00 price objective on shares of UnitedHealth Group in a research report on Friday, October 9th. Bank of America reiterated a “buy” rating and issued a $450.00 price target on shares of UnitedHealth Group in a research note on Monday, July 20th. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $526.00 to $487.00 and set an “overweight” rating on the stock in a research report on Tuesday. UBS Group reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Finally, Argus upped their price objective on UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.
Check Out Our Latest Analysis on UNH
Insider Buying and Selling at UnitedHealth Group
In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.19% of the company’s stock.
UnitedHealth Group Price Performance
Shares of UNH opened at $406.67 on Friday. The firm has a market capitalization of $365.02 billion, a PE ratio of 23.23, a PEG ratio of 1.49 and a beta of 0.60. The company’s 50-day moving average is $390.20 and its 200-day moving average is $362.40. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the previous year, the firm posted $2.59 EPS. UnitedHealth Group’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio is presently 53.00%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.
The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.
Read More
- Five stocks we like better than UnitedHealth Group
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
